ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HTWR Heartware International, Inc. (MM)

57.98
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Heartware International, Inc. (MM) NASDAQ:HTWR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 57.98 57.95 65.00 0 00:00:00

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of HeartWare International, Inc. And Encourage...

29/06/2016 3:00am

Business Wire


Heartware International, Inc. (MM) (NASDAQ:HTWR)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more Heartware International, Inc. (MM) Charts.

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of HeartWare International, Inc. (NASDAQ: HTWR) (“HeartWare” or the “Company”) relating to the proposed buyout of HeartWare by Medtronic plc.

Under the terms of the agreement, HeartWare shareholders are anticipated to receive $58.00 in cash for each share of HeartWare common stock held. The firm’s investigation seeks to determine, among other things, whether the Company’s Board of Directors failed to satisfy their duties to shareholders, including whether the Board adequately pursued alternatives to the acquisition and whether the Board obtained the best price possible for the Company’s shares of common stock. The transaction may undervalue the Company and would result in no real gain or a loss for many long-term shareholders, especially given that, according to Yahoo! Finance, at least one Wall Street analyst has issued a price target for HeartWare stock at $60.00 per share and the 52-week high for HeartWare stock is $94.15.

If you currently own common stock of HeartWare and believe that the proposed buyout price is too low, or you would like to learn more about the investigation being conducted by Brower Piven, please visit our website at http://www.browerpiven.com/currentinvestigations.html. You may also request more information by contacting Brower Piven either by email at hoffman@browerpiven.com or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.

Brower Piven, A Professional CorporationCharles J. Piven, 410-415-66161925 Old Valley RoadStevenson, Maryland 21153hoffman@browerpiven.com

1 Year Heartware International, Inc. (MM) Chart

1 Year Heartware International, Inc. (MM) Chart

1 Month Heartware International, Inc. (MM) Chart

1 Month Heartware International, Inc. (MM) Chart

Your Recent History

Delayed Upgrade Clock